Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Barbieri

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|June 14, 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate CancerSpyridon P Basourakos, Michael Tzeng, Patrick J Lewicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentJacqueline Fontugne, Daniel Lee, Chiara Cantaloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Evidence for molecular differences in prostate cancer between African American and Caucasian menFrancesca Khani, Juan Miguel Mosquera, Kyung Park, et al.
The Prostate|June 10, 2023
Prostate cancer genetic alterations in Hispanic menCamilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Nature Reviews. Urology|August 9, 2022
Race and prostate cancer: genomic landscapeCamilo Arenas-Gallo, Jude Owiredu, Ilon Weinstein, et al.
European Urology|April 8, 2017
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase InhibitionAditya Dutta, Sukanya Panja, Renu K Virk, et al.
Urologic Oncology|March 21, 2020
Prognostic value of the SPOP mutant genomic subclass in prostate cancerJonathan Shoag, Deli Liu, Xiaoyue Ma, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|June 14, 2021
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate CancerSpyridon P Basourakos, Michael Tzeng, Patrick J Lewicki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 12, 2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentJacqueline Fontugne, Daniel Lee, Chiara Cantaloni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Evidence for molecular differences in prostate cancer between African American and Caucasian menFrancesca Khani, Juan Miguel Mosquera, Kyung Park, et al.
The Prostate|June 10, 2023
Prostate cancer genetic alterations in Hispanic menCamilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Nature Reviews. Urology|August 9, 2022
Race and prostate cancer: genomic landscapeCamilo Arenas-Gallo, Jude Owiredu, Ilon Weinstein, et al.
European Urology|April 8, 2017
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase InhibitionAditya Dutta, Sukanya Panja, Renu K Virk, et al.
Urologic Oncology|March 21, 2020
Prognostic value of the SPOP mutant genomic subclass in prostate cancerJonathan Shoag, Deli Liu, Xiaoyue Ma, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 11